AEGiS-Reuters: 'Cell Suicide' Worm Work Wins Medicine Nobel

Reuters, Ltd.Important note: Information in this article was accurate in 2002. The state of the art may have changed since the publication date.
Click here to return to Reuters main menu


DonateNow


'Cell Suicide' Worm Work Wins Medicine Nobel

Reuters NewMedia - October 07, 2002
Anna Peltola


STOCKHOLM (Reuters) - Three scientists whose studies of a tiny worm shed new light on killer diseases such as AIDS and cancer won the 2002 Nobel Medicine Prize Monday.

Sydney Brenner and Sir John Sulston of Britain and Robert Horvitz of the United States share the $1 million prize for work on how genes regulate organ development and cell death, said Sweden's Karolinska Institute, which awards the prize.

Programmed cell death -- or "cell suicide" -- is a natural and necessary process in which billions of cells die every day while a similar number of new ones are created to allow the body and the nervous system to develop.

But in some diseases, such as AIDS, cells are lost due to excessive cell death, while others like cancer reflect a slowdown of this natural cell death. This means that cells -- including cancer cells -- that would usually die, survive.

"Knowledge of programmed cell death has helped us to understand the mechanisms by which some viruses and bacteria invade our cells," the institute said.

"We also know that in AIDS, neurogenerative diseases, stroke and myocardial infarction (heart attack), cells are lost as a result of excessive cell death."

Many researchers, including those focusing on cancer, are now investigating programmed cell death, and many treatments are based on manipulation of the cellular "suicide program." Sten Orrenius, professor of toxicology at the Karolinska Institute, said knowledge of how to stop cell suicide could help prevent the spread of deadly diseases such as ebola, a hemorrhagic fever which has no known cure or vaccine.

"I think within five years we could see medicine, based on this principle, for myocardical infarction and blood poisoning," he told Reuters.

WORK ON WORM

Brenner, 75, Sulston, 60, and Horvitz, 55, worked on the roundworm -- a primitive animal only one millimeter long -- to look into how genes control animal development and cell death.

It was Brenner who realized that the transparent worm's simple structure made it ideal for research.

Brenner, born in South Africa, started to study the worm in the 1960s and showed that different mutations in its body could be linked to specific genes and effects on development.

Sulston extended Brenner's work, describing the visible steps of the cell death process and demonstrating the first mutations of genes that took part in the process.

Sulston also sequenced the worm's genome or its genetic blueprint in 1998, the first time a living animal's genes had been mapped -- akin to creating a geographical atlas or coded instructions needed to make the animal.

From 1992 to 2000 he headed the Sanger Center in Cambridge, the British unit of a global team mapping the human genome.

Sulston is one of the scientists demanding that the genetic blueprint should be freely available, calling genome sequencing for commercial gain "totally immoral and disgusting."

Tall, white-haired and bearded, the unassuming scientist was knighted in 2001.

Sulston was at his desk at the Sanger Center when he received news of the award.

"He is absolutely delighted and thrilled," said Don Powell, a spokesman for the Institute.

"It is tremendously exciting for him and for the worm community, which has been a co-operative community and one which has been founded upon the sharing of data," he added.

Horvitz used the worm to study whether there was a genetic program controlling cell death. He identified certain "death genes" and showed they were a prerequisite for cell mortality.

"I would find nothing more gratifying (than if) one or more of my discoveries led to cures for... human diseases. That's the dream," he said.

Horvitz believed no such treatments were being used today but many pharmaceutical companies are using major scientific discoveries in their work to make treatments for human diseases.

In 1996, Brenner founded the Molecular Sciences Institute in California, combining genome study with computer modeling.

"I don't want to retire to play golf," he said in an interview last year. "Science is one's hobby and one's work and one's pleasure."


021007
RE021013


Copyright © 2002 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.   Contact Reuters.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .